165 related articles for article (PubMed ID: 34475068)
21. HIF1α promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer.
Zheng H; Yu S; Zhu C; Guo T; Liu F; Xu Y
Exp Cell Res; 2021 Jan; 398(2):112394. PubMed ID: 33242463
[TBL] [Abstract][Full Text] [Related]
22. The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression.
Zhong X; Chen B; Yang Z
Cell Physiol Biochem; 2018; 45(1):356-365. PubMed ID: 29402795
[TBL] [Abstract][Full Text] [Related]
23. Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases.
Gazzillo A; Polidoro MA; Soldani C; Franceschini B; Lleo A; Donadon M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555840
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
Hou S; Zhao Y; Chen J; Lin Y; Qi X
J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
[TBL] [Abstract][Full Text] [Related]
25. FAM198B promotes colorectal cancer progression by regulating the polarization of tumor-associated macrophages via the SMAD2 signaling pathway.
Zheng X; Chen J; Nan T; Zheng L; Lan J; Jin X; Cai Y; Liu H; Chen W
Bioengineered; 2022 May; 13(5):12435-12445. PubMed ID: 35587159
[TBL] [Abstract][Full Text] [Related]
26. The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.
Nowak M; Klink M
Cells; 2020 May; 9(5):. PubMed ID: 32456078
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment].
Hang Q; Ying H; Cheng G; Yang S; Jin J; Chen Y; Chen Q; Jiang Y; Zhao Q; Fang M; Chen M; Lai X
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):837-844. PubMed ID: 33070512
[TBL] [Abstract][Full Text] [Related]
28. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
[TBL] [Abstract][Full Text] [Related]
29. CXCL1/IGHG1 signaling enhances crosstalk between tumor cells and tumor-associated macrophages to promote MC-LR-induced colorectal cancer progression.
Wang L; Chen W; Jin H; Tan Y; Guo C; Fu W; Wu Z; Cui K; Wang Y; Qiu Z; Zhang G; Liu W; Zhou Z
Environ Pollut; 2024 Jun; 351():124081. PubMed ID: 38697251
[TBL] [Abstract][Full Text] [Related]
30. Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages.
Wang H; Shao Q; Wang J; Zhao L; Wang L; Cheng Z; Yue C; Chen W; Wang H; Zhang Y
Cancer Lett; 2022 Mar; 529():112-125. PubMed ID: 34999169
[TBL] [Abstract][Full Text] [Related]
31. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
[TBL] [Abstract][Full Text] [Related]
32. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.
Wang H; Tian T; Zhang J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445193
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
34. Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery.
Ammendola M; Patruno R; Sacco R; Marech I; Sammarco G; Zuccalà V; Luposella M; Zizzo N; Gadaleta C; Porcelli M; Gadaleta CD; Ribatti D; Ranieri G
Expert Opin Ther Targets; 2016; 20(5):533-40. PubMed ID: 26914851
[TBL] [Abstract][Full Text] [Related]
35. Cetuximab enhances the anti-tumor function of macrophages in an IL-6 dependent manner.
Zhao Y; Liu X; Huo M; Wang Y; Li Y; Xu N; Zhu H
Life Sci; 2021 Feb; 267():118953. PubMed ID: 33359746
[TBL] [Abstract][Full Text] [Related]
36. Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge.
Scheurlen KM; Billeter AT; O'Brien SJ; Galandiuk S
Cancer Med; 2020 Sep; 9(18):6679-6693. PubMed ID: 33624450
[TBL] [Abstract][Full Text] [Related]
37. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
[TBL] [Abstract][Full Text] [Related]
38. [Research progress on tumor-associated macrophages in colorectal cancer].
Huang S; Li F; Jin D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):940-945. PubMed ID: 37882718
[TBL] [Abstract][Full Text] [Related]
39. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
Zhu Z; Hou Q; Guo H
Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
[TBL] [Abstract][Full Text] [Related]
40. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
